Endocrinología Clínica XII

 

e.191

Izaola O, de Luis DA, Sajoux I, Domingo JC, Vidal M. “Inflamación y obesidad “Nutr Hosp 2015; 31:2352-2358 FI 1,305 


·
e.192

Aller R, Izaola O, Rebollo L, Pacheco D, de Luis DA. “Predictive factors of non alcoholic steatohepatitis: relationship with metabolic syndrome”, Nutr Hosp 2015;31:2496-2502 FI 1,305 


·
e.193

Sainz-Esteban A, Olmos R, González-Sagrado M, González ML, Ruiz MA, García-Talavera P, Gamazo C, Villanueva JG, Cobo A, de Luis DA. “Contribution of 111In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours”. Nucl Med Commun. 2015 Mar;36(3):251-9 FI 1,371


·
e.194

DA de Luis , Aller R, de la Fuente B, Primo D, Conde R, Izaola O, “Sagrado MG. Relation of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor with Weight, Cardiovascular Risk Factor, and Serum Adipokine Levels in Obese Female Subjects”.  J Clin Lab Anal. 2015;29:100-5.


·
e.195

Laura Senovilla, Lucía Núñez, José María de Campos , DA. de Luis , Enrique Romero, Javier García-Sancho,  Carlos Villalobos. “Single-cell phenotypic characterization of human pituitary GHomas and non-functioning adenomas based on hormone content and calcium responses to hypothalamic releasing hormones” Front. Oncol. 5:124. doi: 10.3389/fonc.2015.00124 FI


·
e.196

Castrillón JL, Díaz-Soto G, Izaola O, Romero E, de Luis Román D. Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism. Endocrine. 2015 Dec;50(3):816-8. IF 3,878 


·
e.197

R Aller, DA de Luis. Reply to the letter “Effect of antioxidante agents in patients with hepatocellular diseases. Eur Rev Med PharamcolSci 2015;19:3996-3997 FI 1.213


·